iShares Genomics Immunology and Healthcare ETF
IDNA
66 hedge funds and large institutions have $48.8M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.
35% more capital invested
Capital invested by funds: $36.1M → $48.8M (+$12.7M)
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
7.5% more ownership
Funds ownership: 29.35% → 36.85% (+7.5%)
0% more funds holding
Funds holding: 66 → 66 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$6.64M |
| 2 |
Morgan Stanley
New York
|
+$1.8M |
| 3 |
CCA
Clearwater Capital Advisors
Hoffman Estates,
Illinois
|
+$1.08M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$804K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$1.66M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.32M |
| 3 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$768K |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$285K |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
-$213K |
IDNA Hedge Fund Activity: Q4 2023 in Review
66 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2023, worth a combined $48.8M — up 35% from $36.1M a quarter earlier.
Fund positioning in IDNA was balanced in Q4 2023: 11 funds opened new positions, 11 closed out, 21 added to existing stakes and 19 trimmed.
The largest buyer was Jane Street, adding an estimated $6.64M. The largest seller was Wharton Business Group, cutting an estimated $1.66M.
- 66 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $48.8M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2023, up 35% quarter-over-quarter.
- 11 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2023 and 11 closed out, a net change of 0 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2023 was Jane Street, an estimated $6.64M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2023 was Wharton Business Group, an estimated $1.66M sold.
Based on aggregated 13F filings for Q4 2023.